iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022

NEXT STORY
Atossa Therapeutics Begins Enrollment of Phase 2 Clinical Study of Oral Endoxifen in Sweden
PREV STORY
Automated Immunoassay Analysers Market Report Up to 2031: Visiongain Research Inc
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TESARO Announces Closing of $155 Million Private Placement

WALTHAM, Mass., March 18, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

author_avatar
NASDAQ Market News

Refugees Need to Be Vetted for Health Reasons as Well as Terrorist Connections, States the Association of American Physicians and Surgeons (AAPS)

TUCSON, Ariz., Nov. 03, 2016 (GLOBE NEWSWIRE) -- In the argument over immigration policy, ...

author_avatar
NASDAQ Market News

Embolotherapy Market Research Report by Product, by Disease Indication, by Procedure, by End User, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19

author_avatar
NASDAQ Market News